IceCure Medical (ICCM) to Release Earnings on Tuesday

IceCure Medical (NASDAQ:ICCM) is set to post its quarterly earnings results before the market opens on Tuesday, August 20th. Analysts expect IceCure Medical to post earnings of ($0.07) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

IceCure Medical (NASDAQ:ICCM) last posted its earnings results on Tuesday, May 28th. The company reported ($0.08) EPS for the quarter, hitting the consensus estimate of ($0.08). IceCure Medical had a negative return on equity of 101.66% and a negative net margin of 444.30%. The business had revenue of $0.74 million during the quarter, compared to the consensus estimate of $0.80 million. During the same quarter last year, the company earned ($0.08) EPS. On average, analysts expect IceCure Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

IceCure Medical Trading Up 2.1 %

Shares of ICCM opened at $0.59 on Monday. The stock has a fifty day moving average price of $0.72 and a two-hundred day moving average price of $1.04. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.88 and a current ratio of 3.39. IceCure Medical has a 52-week low of $0.52 and a 52-week high of $1.57. The company has a market cap of $26.92 million, a price-to-earnings ratio of -1.79 and a beta of 0.57.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and issued a $3.00 target price on shares of IceCure Medical in a research note on Tuesday, July 2nd.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.